Article Versions Notes

Hsu C-K, Su S-C, Chang L-C, Yang K-J, Lee C-C, Hsu H-J, Chen Y-T, Sun C-Y, Wu I-W. Oral Absorbent AST-120 Is Associated with Compositional and Functional Adaptations of Gut Microbiota and Modification of Serum Short and Medium-Chain Fatty Acids in Advanced CKD Patients. Biomedicines. 2022; 10(9):2234. https://doi.org/10.3390/biomedicines10092234

Hsu, Cheng-Kai, Shih-Chi Su, Lun-Ching Chang, Kai-Jie Yang, Chin-Chan Lee, Heng-Jung Hsu, Yih-Ting Chen, Chiao-Yin Sun, and I-Wen Wu. 2022. "Oral Absorbent AST-120 Is Associated with Compositional and Functional Adaptations of Gut Microbiota and Modification of Serum Short and Medium-Chain Fatty Acids in Advanced CKD Patients" Biomedicines 10, no. 9: 2234. https://doi.org/10.3390/biomedicines10092234

Hsu, C.-K., Su, S.-C., Chang, L.-C., Yang, K.-J., Lee, C.-C., Hsu, H.-J., Chen, Y.-T., Sun, C.-Y., & Wu, I.-W. (2022). Oral Absorbent AST-120 Is Associated with Compositional and Functional Adaptations of Gut Microbiota and Modification of Serum Short and Medium-Chain Fatty Acids in Advanced CKD Patients. Biomedicines, 10(9), 2234. https://doi.org/10.3390/biomedicines10092234